The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Evaluating the effect of tobacco on prostate cancer outcomes with VEGF-targeted therapy.
Andrea Lynne Harzstark
No relevant relationships to disclose
Susan Halabi
Research Funding - Sanofi
William Kevin Kelly
Research Funding - Sanofi
Michael J. Morris
Consultant or Advisory Role - Sanofi (U)
Research Funding - Sanofi
Phillip G. Febbo
No relevant relationships to disclose
Eric Jay Small
No relevant relationships to disclose